Chinese solar giant JinkoSolar (JKS) saw fourth-quarter revenue grow 21.5% to $1.12 billion, pushing net profit to $16.3 million or $0.40 per share, as it posted its results before opening bell on Friday. However, this came in below the market expectations — analysts were looking for earnings of $0.72 a share on revenue of $1.29 billion for the three-month period.
The quarter saw total solar module shipments of 3,618 MW, up 45.8% year-over-year.
JKS shares fell 3.1% during pre-market trading on Friday. The stock has gained 96% so far this year, though it ended its last trading session down 9% on Thursday.
JinkoSolar now expects first-quarter total solar module shipments to be in the range of 2.8 GW to 3.0 GW. For the full year 2019, the Chinese firm estimates total solar module shipments to be in the range of 14.0 GW to 15.0 GW.
CEO Kangping Chen said, “US demand continues to strengthen thanks to the introduction of the solar Investment Tax Credit (ITC) which is expected to generate robust growth during the second half of 2019.”
Earlier this month, Korea-based Hanwha Q Cells had filed a patent infringement lawsuit claiming that JinkoSolar had used its patented solar cell passivation technology on its solar cells. However, JinkoSolar has refuted these allegations stating that there is no legal merit.
READ: CANADIAN SOLAR BEATS Q4 ESTIMATES, PROFIT JUMPS
It also added the lawsuit would not affect its operations in any way. During the earnings conference call, the management may provide more updates on the same.
Globally, there is improved demand for solar panels as module prices have come down. Solar projects are expected to increase in 2019 and beyond, which is a long-term growth driver for JinkoSolar.
The company would also benefit from increased shipments from China, US, Europe, and Middle East regions in the near future.
Earnings Calendar: Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!
Most Popular
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to
Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights
Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per
BA Earnings: Highlights of Boeing’s Q1 2024 financial results
The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,
